Helen K. Chew

9.6k total citations · 1 hit paper
89 papers, 5.4k citations indexed

About

Helen K. Chew is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Helen K. Chew has authored 89 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 22 papers in Molecular Biology and 19 papers in Cancer Research. Recurrent topics in Helen K. Chew's work include Cancer Treatment and Pharmacology (18 papers), Venous Thromboembolism Diagnosis and Management (16 papers) and Breast Cancer Treatment Studies (15 papers). Helen K. Chew is often cited by papers focused on Cancer Treatment and Pharmacology (18 papers), Venous Thromboembolism Diagnosis and Management (16 papers) and Breast Cancer Treatment Studies (15 papers). Helen K. Chew collaborates with scholars based in United States, China and United Kingdom. Helen K. Chew's co-authors include Hong Zhou, Richard H. White, Danielle Harvey, Theodore Wun, Ted Wun, William J. Gradishar, Suzanne Miyamoto, Carlito B. Lebrilla, Hyun Joo An and Ted Wun and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Bioinformatics.

In The Last Decade

Helen K. Chew

88 papers receiving 5.3k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence of Venous Thromboembolism and Its Effect on Survival Among Patients With Common Cancers

2006 985 citations Helen K. Chew, Danielle Harvey et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helen K. Chew United States	34	2.2k	1.4k	1.2k	1.0k	837	89	5.4k
Susanne Osanto Netherlands	37	940 0.4×	1.4k 1.0×	738 0.6×	1.9k 1.8×	259 0.3×	95	5.1k
Soo‐Mee Bang South Korea	35	695 0.3×	2.3k 1.6×	455 0.4×	682 0.7×	176 0.2×	295	5.0k
Ted Wun United States	28	854 0.4×	392 0.3×	454 0.4×	225 0.2×	329 0.4×	75	2.9k
Ted Wun United States	35	867 0.4×	450 0.3×	538 0.4×	423 0.4×	272 0.3×	114	3.8k
Binita Shah United States	30	346 0.2×	487 0.3×	1.7k 1.4×	874 0.8×	197 0.2×	124	4.5k
Maurizio Tonato Italy	41	442 0.2×	3.3k 2.3×	364 0.3×	1.4k 1.3×	215 0.3×	174	6.8k
Alì Taher Lebanon	58	612 0.3×	660 0.5×	965 0.8×	1.1k 1.0×	129 0.2×	533	14.6k
Randolph S. Marks United States	41	279 0.1×	2.7k 1.9×	233 0.2×	1.4k 1.4×	123 0.1×	121	5.9k
Gerard M.J. Bos Netherlands	34	606 0.3×	908 0.6×	328 0.3×	698 0.7×	44 0.1×	134	4.7k
Marsha E. Reichman United States	36	552 0.2×	2.1k 1.5×	1.2k 1.0×	1.1k 1.1×	20 0.0×	65	7.7k

Countries citing papers authored by Helen K. Chew

Since Specialization

Citations

This map shows the geographic impact of Helen K. Chew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen K. Chew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen K. Chew more than expected).

Fields of papers citing papers by Helen K. Chew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen K. Chew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen K. Chew. The network helps show where Helen K. Chew may publish in the future.

Co-authorship network of co-authors of Helen K. Chew

This figure shows the co-authorship network connecting the top 25 collaborators of Helen K. Chew. A scholar is included among the top collaborators of Helen K. Chew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen K. Chew. Helen K. Chew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cinar, Pelin, Richard J. Bold, Daniela A. Bota, et al.. (2020). Planning for post‐pandemic cancer care delivery: Recovery or opportunity for redesign?. CA A Cancer Journal for Clinicians. 71(1). 34–46. 14 indexed citations

Hausner, Sven H., Richard J. Bold, Helen K. Chew, et al.. (2018). Preclinical Development and First-in-Human Imaging of the Integrin αvβ6 with [18F]αvβ6-Binding Peptide in Metastatic Carcinoma. Clinical Cancer Research. 25(4). 1206–1215. 81 indexed citations

Somlo, George, Paul Frankel, Thehang Luu, et al.. (2015). Efficacy of the PARP inhibitor (PI) ABT-888 (veliparib [vel]) either with carboplatin (carb) or as a single agent followed by post-progression therapy in combination with carb in patients (pts) with BRCA1- or BRCA2- (BRCA)-associated metastatic breast cancer (MBC).. Journal of Clinical Oncology. 33(15_suppl). 520–520. 8 indexed citations

Shanafelt, Tait D., Marilyn Raymond, Leora Horn, et al.. (2014). Oncology Fellows' Career Plans, Expectations, and Well-Being: Do Fellows Know What They Are Getting Into?. Journal of Clinical Oncology. 32(27). 2991–2997. 46 indexed citations

Mahajan, Anjlee, Ted Wun, Helen K. Chew, & Richard H. White. (2014). Lymphoma and venous thromboembolism: influence on mortality. Thrombosis Research. 133. S23–S28. 34 indexed citations

Hortobágyi, Gabriel N., Allan Lipton, Helen K. Chew, et al.. (2014). Efficacy and safety of continued zoledronic acid every 4 weeks versus every 12 weeks in women with bone metastases from breast cancer: Results of the OPTIMIZE-2 trial.. Journal of Clinical Oncology. 32(18_suppl). LBA9500–LBA9500. 21 indexed citations

Gralow, Julie R., William E. Barlow, Alexander Paterson, et al.. (2014). SWOG S0307 phase III trial of bisphosphonates as adjuvant therapy in primary breast cancer: Comparison of toxicities and patient-stated preference for oral versus intravenous delivery.. Journal of Clinical Oncology. 32(15_suppl). 558–558. 9 indexed citations

Shanafelt, Tait D., William J. Gradishar, Michael P. Kosty, et al.. (2014). Burnout and Career Satisfaction Among US Oncologists. Journal of Clinical Oncology. 32(7). 678–686. 274 indexed citations

Ho, Cheryl, Angela M. Davies, Randeep Sangha, et al.. (2013). Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer. Investigational New Drugs. 31(6). 1587–1591. 8 indexed citations

10.

Budd, G. Thomas, William E. Barlow, Halle C. F. Moore, et al.. (2013). S0221: Comparison of two schedules of paclitaxel as adjuvant therapy for breast cancer.. Journal of Clinical Oncology. 31(15_suppl). CRA1008–CRA1008. 8 indexed citations

11.

Chew, Helen K., George Somlo, Philip C. Mack, et al.. (2011). Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumors. Annals of Oncology. 23(4). 1023–1029. 14 indexed citations

12.

Sneed, Kevin, et al.. (2011). Clinical Herbal Interactions with Conventional Drugs: From Molecules to Maladies. Current Medicinal Chemistry. 18(31). 4836–4850. 87 indexed citations

13.

Ku, Grace, Richard H. White, Helen K. Chew, et al.. (2008). Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood. 113(17). 3911–3917. 136 indexed citations

14.

Chew, Helen K., William E. Barlow, Kathy S. Albain, et al.. (2008). A Phase II Study of Imatinib Mesylate and Capecitabine in Metastatic Breast Cancer: Southwest Oncology Group Study 0338. Clinical Breast Cancer. 8(6). 511–515. 31 indexed citations

15.

Xiao, Gary Guishan, George Somlo, Jana Portnow, et al.. (2008). Identification of F-box/LLR-repeated protein 17 as potential useful biomarker for breast cancer therapy.. PubMed. 5(3-4). 151–60. 12 indexed citations

16.

Rodriguez, Anne O., Ted Wun, Helen K. Chew, et al.. (2007). Venous thromboembolism in ovarian cancer. Gynecologic Oncology. 105(3). 784–790. 126 indexed citations

17.

Juhász, Ágnes, Aikaterini Vassilakos, Helen K. Chew, David R. Gandara, & Yun Yen. (2006). Analysis of ribonucleotide reductase M2 mRNA levels in patient samples after GTI-2040 antisense drug treatment. Oncology Reports. 15(5). 1299–304. 20 indexed citations

18.

Mohsin, Syed K., D. Craig Allred, C. Kent Osborne, et al.. (2005). Morphologic and Immunophenotypic Markers as Surrogate Endpoints of Tamoxifen Effect for Prevention of Breast Cancer. Breast Cancer Research and Treatment. 94(3). 205–211. 14 indexed citations

19.

Chew, Helen K.. (2002). Medical Management of Breast Cancer: Today and Tomorrow. Cancer Biotherapy and Radiopharmaceuticals. 17(2). 137–149. 13 indexed citations

20.

Chen, Yumay, Wen‐Hwa Lee, & Helen K. Chew. (1999). Emerging roles of BRCA1 in transcriptional regulation and DNA repair. Journal of Cellular Physiology. 181(3). 385–392. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact